Table 3.

Glucose metabolism profile at baseline and 12 months of intervention

Variable	Individual intervention (n = 76)	Collective intervention (n = 77)	p-value
Glucose (mmol/L)
Baseline	4.76 (4.69 to 4.83)	4.76 (4.64 to 8.88)	0.593
12 months	4.73 (4.66 to 4.79)	4.58 (4.52 to 4.66)	0.404
p-value	0.597	0.273
Insulin (pmol/L)
Baseline	122.93 (104.38 to 141.49)	120.98 (100.43 to 141.53)	0.347
12 months	99.87 (85.69 to 112.05)	100.63 (85.10 to 116.16)	0.615
p-value	0.003	0.009
HOMA to IR
Baseline	3.78 (3.09 to 4.26)	3.68 (2.98 to 4.37)	0.190
12 months	3.06 (2.63 to 3.49)	3.54 (2.87 to 4.21)	0.830
p-value	0.005	0.662
HOMA to β%
Baseline	291.92 (247.59 to 366.25)	335.49 (275.87 to 395.11)	0.334
12 months	233.32 (206.29 to 260.35)	251.98 (219.05 to 284.92)	0.773
p-value	0.010	< 0.001
QUICK index
Baseline	0.32 (0.31 to 0.33)	0.33 (0.32 to 0.34)	0.161
12 months	0.33 (0.32 to 0.34)	0.33 (0.32 to 0.34)	0.492
p-value	0.007	0.156
TyG index
Baseline	8.29 (8.18 to 8.39)	8.18 (8.07 to 2.89)	0.116
12 months	8.07 (7.98 to 8.16)	8.10 (8.01 to 8.19)	0.668
p-value	0.003	0.124

Values are mean (95%CI)

HOMA to IR homeostatic model assessment of insulin resistance, HOMA to β% homeostatic model assessment of β to cell function, QUICK quantitative insulin sensitivity check, TyG triglyceride to glucose